Evidence map›Paper›PMID 42646581›Full record

ArticleMedical sciences (Basel, Switzerland)2026

Lomerizine Prophylaxis for Pediatric Migraine: Efficacy and Predictors of Treatment Response-A Retrospective Cohort Study.

Hideki Shimomura, Sachi Tokunaga, Naoko Taniguchi, Eisuke Terasaki, Saeka Yoshitake, Ayuko Usami, Shintaro Iwamoto, Yasuhiro Takeshima

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medical sciences (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hideki ShimomuraDepartment of Pediatrics, School of Medicine, Hyogo Medical University, 1-1 Mukogawa, Nishinomiya 663-8501, Hyogo, Japan.ORCID 0000-0002-0815-9193
Sachi TokunagaDepartment of Pediatrics, School of Medicine, Hyogo Medical University, 1-1 Mukogawa, Nishinomiya 663-8501, Hyogo, Japan.
Naoko TaniguchiDepartment of Pediatrics, School of Medicine, Hyogo Medical University, 1-1 Mukogawa, Nishinomiya 663-8501, Hyogo, Japan.
Eisuke TerasakiDepartment of Pediatrics, Kawanishi City Medical Center, 1-4-1 Hiuchi, Kawanishi City 666-0017, Hyogo, Japan.
Saeka YoshitakeDepartment of Pediatrics, School of Medicine, Hyogo Medical University, 1-1 Mukogawa, Nishinomiya 663-8501, Hyogo, Japan.
Ayuko UsamiDepartment of Pediatrics, School of Medicine, Hyogo Medical University, 1-1 Mukogawa, Nishinomiya 663-8501, Hyogo, Japan.
Shintaro IwamotoDepartment of Pediatrics, School of Medicine, Hyogo Medical University, 1-1 Mukogawa, Nishinomiya 663-8501, Hyogo, Japan.
Yasuhiro TakeshimaDepartment of Pediatrics, School of Medicine, Hyogo Medical University, 1-1 Mukogawa, Nishinomiya 663-8501, Hyogo, Japan.ORCID 0000-0002-6468-7185

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Calcium Channel BlockersMigraine DisordersPiperazinesAdolescentChildFemaleHumansMaleRetrospective StudiesTreatment OutcomeCalcium Channel BlockerslomerizinePiperazinescomorbid conditionslomerizinemigrainepediatricpreventive therapypsychosocial factorstreatment response

Identifiers

PMID42646581
PMCPMC13515776

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.